FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

The company says around six million people across 60 countries now use its Freestyle Libre glucose monitors which avoid the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.

Do you struggle to fall asleep at night, or regularly wake up feeling tired? If so, you might find answers by learning about ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

A 75-day public comment period is open starting Oct. 25 for the draft environmental impact statement on what’s commonly referred to as a 36-degree missile defense system for Guam. From the ...

Time spent sedentary beyond six hours per day during growth from childhood through young adulthood may cause an excess ...